CI
MDCO

Cambiar Investors’s Medicines Co MDCO Stock Holding History

Cambiar Investors’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-945,262
Closed -$35.9M – 174
2015
Q3 		$35.9M Sell
945,262
-565,667
-37% -$19.9M 0.53% 72
2015
Q2 		$43.2M Buy
1,510,929
+119,782
+9% +$3.34M 0.61% 66
2015
Q1 		$39M Buy
+1,391,147
New +$39.1M 0.57% 84

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cambiar Investors's MDCO Position: Q4 2015 in Review

Cambiar Investors sold out of Medicines Co (MDCO) in Q4 2015, closing a stake of 945,262 shares — an estimated $35.9M sold.

Cambiar Investors first reported a position in MDCO in Q1 2015 and held it in 3 quarters. The position peaked at $43.2M in Q2 2015. 190 funds tracked by Wall St. Rank hold MDCO as of Q4 2015.

  • Cambiar Investors reported no remaining Medicines Co position as of Q4 2015 after selling out during the quarter.
  • Cambiar Investors sold 945,262 Medicines Co shares in Q4 2015, an estimated $35.9M.
  • Cambiar Investors first reported a position in Medicines Co in Q1 2015 and held it in 3 quarters.
  • Cambiar Investors's Medicines Co position peaked at $43.2M in Q2 2015.
  • 190 funds tracked by Wall St. Rank held Medicines Co as of Q4 2015.

Based on Cambiar Investors's 13F filing for Q4 2015, filed 27 Jan 2016.